Edwards Lifesciences - Stock Split History | EW

Stock split history for Edwards Lifesciences since 2022. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Edwards Lifesciences Annual Stock Splits
Edwards Lifesciences Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $44.873B $5.233B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $218.900B 22.89
Alcon (ALC) Switzerland $33.262B 28.64
STERIS (STE) Ireland $18.523B 23.05
Teleflex (TFX) United States $11.273B 18.29
Fresenius Medical Care AG KGaA (FMS) Germany $9.266B 9.30
Penumbra (PEN) United States $8.355B 2000.00
Globus Medical (GMED) United States $6.995B 35.56
Integer Holdings (ITGR) United States $2.380B 19.11
Glaukos (GKOS) United States $2.160B 0.00
Paragon 28 (FNA) United States $1.535B 0.00
Nevro (NVRO) United States $1.482B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.208B 17.20
Artivion (AORT) United States $0.511B 0.00